Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intestinal Neoplasms × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4 Polycystic Ovary Syndrome 3 Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Venous Thromboembolism 1 Tuberous Sclerosis 1 Thrombosis 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Perioperative Inflammatory Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Margins of Excision 1 Lymphangioleiomyomatosis 1 Long Qt Syndrome 3 1

Interventions

Leucovorin 3 Fluorouracil 3 Oxaliplatin 2 Irinotecan 2 Capecitabine 2 Bisacodyl 2 Bevacizumab 2 5,10-methylenetetrahydrofolic acid 2 trametinib 1 spartalizumab 1 pralsetinib 1 nazartinib 1 napabucasin 1 guadecitabine 1 canakinumab 1 Ursodeoxycholic Acid 1 Tinzaparin 1 Simvastatin 1 Radiotherapy 1 Polyethylene Glycols 1 Pemetrexed 1 Oviposition 1 Ocoxin 1 Mass Screening 1 Levoleucovorin 1 Drainage 1 Cyclophosphamide 1 Colonoscopy 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00994903 2013-12-02

StatCol

University of Auckland, New Zealand

Phase 3 Completed

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡